Lausanne, Switzerland, and Boston, United States: SOPHiA GENETICS, leader in Data-Driven Medicine, today announced that it is entering the fight against the COVID-19 coronavirus by extending its partnership with Paragon Genomics, who developed a next-generation sequencing (NGS) assay and leveraging the SOPHiA Platform analytical capabilities, as well as delivering the benefits of this solution to […]
SOUTH SAN FRANCISCO, Calif.– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Vanderbilt University Medical Center (VUMC) to supply synthetic genes and antibodies for the development of therapies for COVID-19. In addition, Twist Biopharma, a division […]
INTEGRA, BioTools and Sullivan Nicolaides Pathology work together to accelerate COVID-19 testing The global COVID-19 pandemic has placed unprecedented demands on pathology services to test patient samples for the novel SARS-CoV-2 coronavirus alongside their pre-existing respiratory virus panels. This extreme influx of samples quickly exhausted the capacity of existing systems in the Microbiology and Molecular Pathology Department at Sullivan Nicolaides Pathology (SNP) – part of […]
Calgary, Alberta, – FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), a technology company focused on becoming the standard in the analytical Cannabis and Hemp testing market, is pleased to announce it has entered into an non-exclusive US distribution agreement with North Carolina based HempLab Inc. The distribution agreement provides for FluroTech and HempLab to work together […]
Proteona leads international consortium to develop SARS-CoV-2 neutralizing antibody to help vulnerable immunocompromised individuals Innovative AI-driven proteogenomic analysis company applies single cell analysis expertise to developing treatments for COVID-19 The Proteona team is leveraging on its ESCAPE™ single cell proteogenomics platform to discover SARS-CoV-2 neutralizing antibodies. Singapore, 25 March 2020 – Proteona Pte. Ltd. and partners […]
DUBLIN and TAMPA, Florida, — Avectas, a cell engineering technology business and Vycellix, Inc. an immuno-discovery cell & gene therapy company, today announced that the companies have entered into a collaboration agreement to develop proprietary approaches for cell-based immunotherapeutic products. The companies will collaborate on the delivery of Vycellix’s novel RNA immunomodulator VY-M using Avectas’ […]
IsoPlexis teams with industry leaders to accelerate the development of improved detection methods that inform understanding and treatment of COVID-19 BRANFORD, Conn. and SEATTLE — IsoPlexis, the leader in functional cellular proteomics, and the Institute for Systems Biology (ISB) announced a partnership mapping functional immune responses at the single cell level to study COVID-19. Uncovering functional immune responses using […]
VIENNA, AUSTRIA, MARCH 24, 2020 – Lexogen is pleased to announce the appointment of Intra Globus Biosystems Pvt. Ltd (IGB) as its official distributor in India, as a further step in growing its operations in the APAC region. IGB, a subsidiary of Integrated Gulf Biosystems LLC, is a well-established organization headquartered in Dubai, UAE, with a reputation of […]
NEW YORK– Schrödinger (Nasdaq: SDGR), whose physics-based software platform enables discovery of high-quality, novel molecules for therapeutics and materials, today announced an expanded collaboration with AstraZeneca focused on refining a biologics modeling solution with the aim of speeding up the development of antibody and protein-based therapeutic candidates. The multi-year agreement extends an existing collaboration in […]
Calgary, Alberta – FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), a technology company focused on becoming the standard in the analytical Cannabis and Hemp testing market, is pleased to announce it has entered into an non-exclusive US distribution agreement with North Carolina based HempLab Inc. The distribution agreement provides for FluroTech and HempLab to work together […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
